Public Profile

Aloha Medicinals

Aloha Medicinals, a leading name in the biotechnology sector, is headquartered in the United States, with significant operations across North America and beyond. Founded in 2000, the company has established itself as a pioneer in the cultivation and production of medicinal mushrooms, focusing on high-quality mycelium and fruiting body extracts. Aloha Medicinals is renowned for its unique, scientifically-backed products that cater to the health and wellness market, including dietary supplements and functional foods. Their commitment to sustainability and innovation has positioned them as a trusted supplier in the industry, achieving notable milestones such as partnerships with major health brands. With a strong emphasis on research and development, Aloha Medicinals continues to lead the way in harnessing the therapeutic potential of mushrooms, setting a benchmark for quality and efficacy in the market.

DitchCarbon Score

How does Aloha Medicinals's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Education Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

21

Industry Benchmark

Aloha Medicinals's score of 20 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.

30%

Aloha Medicinals's reported carbon emissions

Aloha Medicinals, headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or the scope of their emissions (Scope 1, 2, or 3). However, the absence of data does not preclude the company from engaging in climate commitments or initiatives. As the industry increasingly prioritises sustainability, Aloha Medicinals may be exploring strategies to enhance their environmental performance and align with broader climate goals. Further information on their climate commitments or initiatives would be necessary to provide a comprehensive overview of their efforts in reducing carbon emissions.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Aloha Medicinals's primary industry is Education services (80), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Aloha Medicinals is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Aloha Medicinals is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

SBTi
CDP
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Education Services

BCP Business & Management

SG
Education Services
Updated 12 days ago

University of Birmingham

GB
Education Services
Updated 8 days ago

Manar

US
Education Services
Updated 12 days ago

The Essential Expert

GB
Education Services
Updated 12 days ago

University Of Melbourne

AU
Education Services
Updated 4 days ago

Royal Food Import Corp.

US
Education Services
Updated 12 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers